Timestamp,Zoterokey,Extraction_Initials,Paper,Publicationtype,Country,Study_Description,Study_Type,Enrollment_Setting,Enrollment,Enrollment_Start,Enrollment_End,Outcomes,Participants_Screened,Participants_Enrolled,Participants_Analyzed,Age_Mean,Age_STDEV,Age_Median,Age_Q1,Age_Q3,Percent_Female,Sampling_Site,Mortality_N,Mortality_Female,Age_Mortality_Mean,Age_Mortality_STDEV,Age_Mortality_Median,Age_Mortality_Q1,Age_Mortality_Q3,Mortality_CFR,Other_Mortality_Value,Other_Mortality_Description,Mortality_HR,Mortality_OR,Survived_N,Survived_Female,Age_Survived_Mean,Age_Survived_STDEV,Age_Survived_Median,Age_Survived_Q1,Age_Survived_Q3,Other_Survived_Value,Other_Survived_Description,Survived_HR,Survived_OR,Hosp_N,Hosp_Female,Age_Hosp_Mean,Age_Hosp_STDEV,Age_Hosp_Median,Age_Hosp_Q1,Age_Hosp_Q3,Other_Hosp_Value,Other_Hosp_Description,Hosp_HR,Hosp_OR,Nonhosp_N,Nonhosp_Female,Age_Nonhosp_Mean,Age_Nonhosp_STDEV,Age_Nonhosp_Median,Age_Nonhosp_Q1,Age_Nonhosp_Q3,Other_Nonhosp_Value,Other_Nonhosp_Description,Nonhosp_HR,Nonhosp_OR,ICU_N,ICU_Female,Age_ICU_Mean,Age_ICU_STDEV,Age_ICU_Median,Age_ICU_Q1,Age_ICU_Q3,Other_ICU_Value,Other_ICU_Description,ICU_HR,ICU_OR,NonICU_N,NonICU_Female,Age_NonICU_Mean,Age_NonICU_STDEV,Age_NonICU_Median,Age_NonICU_Q1,Age_NonICU_Q3,Other_NonICU_Value,Other_NonICU_Description,NonICU_HR,NonICU_OR,Intub_N,Intub_Female,Age_Intub_Mean,Age_Intub_STDEV,Age_Intub_Median,Age_Intub_Q1,Age_Intub_Q3,Other_Intub_Value,Other_Intub_Description,Intub_HR,Intub_OR,Nonintub_N,Nonintub_Female,Age_Nonintub_Mean,Age_Nonintub_STDEV,Age_Nonintub_Median,Age_Nonintub_Q1,Age_Nonintub_Q3,Other_Nonintub_Value,Other_Nonintub_Description,Nonintub_HR,Nonintub_OR,Other_N,Other_Value,Other_Description,Other_HR,Other_OR,CRP_ICU_N,CRP_ICU_Mean,CRP_ICU_STDEV,CRP_ICU_LowRange,CRP_ICU_UpRange,CRP_ICU_Median,CRP_ICU_Q1,CRP_ICU_Q3,CRP_ICU_Unit,CRP_NonICU_N,CRP_NonICU_Mean,CRP_NonICU_STDEV,CRP_NonICU_LowRange,CRP_NonICU_UpRange,CRP_NonICU_Median,CRP_NonICU_Q1,CRP_NonICU_Q3,CRP_NonICU_Unit,CRP_Hosp_N,CRP_Hosp_Mean,CRP_Hosp_STDEV,CRP_Hosp_LowRange,CRP_Hosp_UpRange,CRP_Hosp_Median,CRP_Hosp_Q1,CRP_Hosp_Q3,CRP_Hosp_Unit,CRP_Nonhosp_N,CRP_Nonhosp_Mean,CRP_Nonhosp_STDEV,CRP_Nonhosp_LowRange,CRP_Nonhosp_UpRange,CRP_Nonhosp_Median,CRP_Nonhosp_Q1,CRP_Nonhosp_Q3,CRP_Nonhosp_Unit,CRP_Intub_N,CRP_Intub_Mean,CRP_Intub_STDEV,CRP_Intub_LowRange,CRP_Intub_UpRange,CRP_Intub_Median,CRP_Intub_Q1,CRP_Intub_Q3,CRP_Intub_Unit,CRP_Nonintub_N,CRP_Nonintub_Mean,CRP_Nonintub_STDEV,CRP_Nonintub_LowRange,CRP_Nonintub_UpRange,CRP_Nonintub_Median,CRP_Nonintub_Q1,CRP_Nonintub_Q3,CRP_Nonintub_Unit,CRP_Mortality_N,CRP_Mortality_Mean,CRP_Mortality_STDEV,CRP_Mortality_LowRange,CRP_Mortality_UpRange,CRP_Mortality_Median,CRP_Mortality_Q1,CRP_Mortality_Q3,CRP_Mortality_Unit,CRP_Survived_N,CRP_Survived_Mean,CRP_Survived_STDEV,CRP_Survived_LowRange,CRP_Survived_UpRange,CRP_Survived_Median,CRP_Survived_Q1,CRP_Survived_Q3,CRP_Survived_Unit,CRP_Other,CRP_Other_N,CRP_Other_Mean,CRP_Other_STDEV,CRP_Other_LowRange,CRP_Other_UpRange,CRP_Other_Median,CRP_Other_Q1,CRP_Other_Q3,CRP_Other_Unit,Procalcitonin_ICU_N,Procalcitonin_ICU_Mean,Procalcitonin_ICU_STDEV,Procalcitonin_ICU_LowRange,Procalcitonin_ICU_UpRange,Procalcitonin_ICU_Median,Procalcitonin_ICU_Q1,Procalcitonin_ICU_Q3,Procalcitonin_ICU_Unit,Procalcitonin_NonICU_N,Procalcitonin_NonICU_Mean,Procalcitonin_NonICU_STDEV,Procalcitonin_NonICU_LowRange,Procalcitonin_NonICU_UpRange,Procalcitonin_NonICU_Median,Procalcitonin_NonICU_Q1,Procalcitonin_NonICU_Q3,Procalcitonin_NonICU_Unit,Procalcitonin_Hosp_N,Procalcitonin_Hosp_Mean,Procalcitonin_Hosp_STDEV,Procalcitonin_Hosp_LowRange,Procalcitonin_Hosp_UpRange,Procalcitonin_Hosp_Median,Procalcitonin_Hosp_Q1,Procalcitonin_Hosp_Q3,Procalcitonin_Hosp_Unit,Procalcitonin_Nonhosp_N,Procalcitonin_Nonhosp_Mean,Procalcitonin_Nonhosp_STDEV,Procalcitonin_Nonhosp_LowRange,Procalcitonin_Nonhosp_UpRange,Procalcitonin_Nonhosp_Median,Procalcitonin_Nonhosp_Q1,Procalcitonin_Nonhosp_Q3,Procalcitonin_Nonhosp_Unit,Procalcitonin_Intub_N,Procalcitonin_Intub_Mean,Procalcitonin_Intub_STDEV,Procalcitonin_Intub_LowRange,Procalcitonin_Intub_UpRange,Procalcitonin_Intub_Median,Procalcitonin_Intub_Q1,Procalcitonin_Intub_Q3,Procalcitonin_Intub_Unit,Procalcitonin_Nonintub_N,Procalcitonin_Nonintub_Mean,Procalcitonin_Nonintub_STDEV,Procalcitonin_Nonintub_LowRange,Procalcitonin_Nonintub_UpRange,Procalcitonin_Nonintub_Median,Procalcitonin_Nonintub_Q1,Procalcitonin_Nonintub_Q3,Procalcitonin_Nonintub_Unit,Procalcitonin_Mortality_N,Procalcitonin_Mortality_Mean,Procalcitonin_Mortality_STDEV,Procalcitonin_Mortality_LowRange,Procalcitonin_Mortality_UpRange,Procalcitonin_Mortality_Median,Procalcitonin_Mortality_Q1,Procalcitonin_Mortality_Q3,Procalcitonin_Mortality_Unit,Procalcitonin_Survived_N,Procalcitonin_Survived_Mean,Procalcitonin_Survived_STDEV,Procalcitonin_Survived_LowRange,Procalcitonin_Survived_UpRange,Procalcitonin_Survived_Median,Procalcitonin_Survived_Q1,Procalcitonin_Survived_Q3,Procalcitonin_Survived_Unit,Procalcitonin_Other,Procalcitonin_Other_N,Procalcitonin_Other_Mean,Procalcitonin_Other_STDEV,Procalcitonin_Other_LowRange,Procalcitonin_Other_UpRange,Procalcitonin_Other_Median,Procalcitonin_Other_Q1,Procalcitonin_Other_Q3,Procalcitonin_Other_Unit,IL6_ICU_N,IL6_ICU_Mean,IL6_ICU_STDEV,IL6_ICU_LowRange,IL6_ICU_UpRange,IL6_ICU_Median,IL6_ICU_Q1,IL6_ICU_Q3,IL6_ICU_Unit,IL6_NonICU_N,IL6_NonICU_Mean,IL6_NonICU_STDEV,IL6_NonICU_LowRange,IL6_NonICU_UpRange,IL6_NonICU_Median,IL6_NonICU_Q1,IL6_NonICU_Q3,IL6_NonICU_Unit,IL6_Hosp_N,IL6_Hosp_Mean,IL6_Hosp_STDEV,IL6_Hosp_LowRange,IL6_Hosp_UpRange,IL6_Hosp_Median,IL6_Hosp_Q1,IL6_Hosp_Q3,IL6_Hosp_Unit,IL6_Nonhosp_N,IL6_Nonhosp_Mean,IL6_Nonhosp_STDEV,IL6_Nonhosp_LowRange,IL6_Nonhosp_UpRange,IL6_Nonhosp_Median,IL6_Nonhosp_Q1,IL6_Nonhosp_Q3,IL6_Nonhosp_Unit,IL6_Intub_N,IL6_Intub_Mean,IL6_Intub_STDEV,IL6_Intub_LowRange,IL6_Intub_UpRange,IL6_Intub_Median,IL6_Intub_Q1,IL6_Intub_Q3,IL6_Intub_Unit,IL6_Nonintub_N,IL6_Nonintub_Mean,IL6_Nonintub_STDEV,IL6_Nonintub_LowRange,IL6_Nonintub_UpRange,IL6_Nonintub_Median,IL6_Nonintub_Q1,IL6_Nonintub_Q3,IL6_Nonintub_Unit,IL6_Mortality_N,IL6_Mortality_Mean,IL6_Mortality_STDEV,IL6_Mortality_LowRange,IL6_Mortality_UpRange,IL6_Mortality_Median,IL6_Mortality_Q1,IL6_Mortality_Q3,IL6_Mortality_Unit,IL6_Survived_N,IL6_Survived_Mean,IL6_Survived_STDEV,IL6_Survived_LowRange,IL6_Survived_UpRange,IL6_Survived_Median,IL6_Survived_Q1,IL6_Survived_Q3,IL6_Survived_Unit,IL6_Other,IL6_Other_N,IL6_Other_Mean,IL6_Other_STDEV,IL6_Other_LowRage,IL6_Other_UpRange,IL6_Other_Median,IL6_Other_Q1,IL6_Other_Q3,IL6_Other_Unit,CD4_ICU_Value,CD4_ICU_Mean,CD4_ICU_STDEV,CD4_ICU_LowRange,CD4_ICU_UpRange,CD4_ICU_Median,CD4_ICU_Q1,CD4_ICU_Q3,CD4_ICU_Unit,CD4_NonICU_Value,CD4_NonICU_Mean,CD4_NonICU_STDEV,CD4_NonICU_LowRange,CD4_NonICU_UpRange,CD4_NonICU_Median,CD4_NonICU_Q1,CD4_NonICU_Q3,CD4_NonICU_Unit,CD4_Hosp_Value,CD4_Hosp_Mean,CD4_Hosp_STDEV,CD4_Hosp_LowRange,CD4_Hosp_UpRange,CD4_Hosp_Median,CD4_Hosp_Q1,CD4_Hosp_Q3,CD4_Hosp_Unit,CD4_Nonhosp_Value,CD4_Nonhosp_Mean,CD4_Nonhosp_STDEV,CD4_Nonhosp_LowRange,CD4_Nonhosp_UpRange,CD4_Nonhosp_Median,CD4_Nonhosp_Q1,CD4_Nonhosp_Q3,CD4_Nonhosp_Unit,CD4_Intub_Value,CD4_Intub_Mean,CD4_Intub_STDEV,CD4_Intub_LowRange,CD4_Intub_UpRange,CD4_Intub_Median,CD4_Intub_Q1,CD4_Intub_Q3,CD4_Intub_Unit,CD4_Nonintub_Value,CD4_Nonintub_Mean,CD4_Nonintub_STDEV,CD4_Nonintub_LowRange,CD4_Nonintub_UpRange,CD4_Nonintub_Median,CD4_Nonintub_Q1,CD4_Nonintub_Q3,CD4_Nonintub_Unit,CD4_Mortality_Value,CD4_Mortality_Mean,CD4_Mortality_STDEV,CD4_Mortality_LowRange,CD4_Mortality_UpRange,CD4_Mortality_Median,CD4_Mortality_Q1,CD4_Mortality_Q3,CD4_Mortality_Unit,CD4_Survived_Value,CD4_Survived_Mean,CD4_Survived_STDEV,CD4_Survived_LowRange,CD4_Survived_UpRange,CD4_Survived_Median,CD4_Survived_Q1,CD4_Survived_Q3,CD4_Survived_Unit,CD4_Other,CD4_Other_Value,CD4_Other_Mean,CD4_Other_STDEV,CD4_Other_LowRange,CD4_Other_UpRange,CD4_Other_Median,CD4_Other_Q1,CD4_Other_Q3,CD4_Other_Unit,ViralLoad_ICU_N,ViralLoad_ICU_Mean,ViralLoad_ICU_STDEV,ViralLoad_ICU_LowRange,ViralLoad_ICU_UpRange,ViralLoad_ICU_Median,ViralLoad_ICU_Q1,ViralLoad_ICU_Q3,ViralLoad_ICU_Unit,ViralLoad_NonICU_N,ViralLoad_NonICU_Mean,ViralLoad_NonICU_STDEV,ViralLoad_NonICU_LoWRange,ViralLoad_NonICU_UpRange,ViralLoad_NonICU_Median,ViralLoad_NonICU_Q1,ViralLoad_NonICU_Q3,ViralLoad_NonICU_Unit,ViralLoad_Hosp_N,ViralLoad_Hosp_Mean,ViralLoad_Hosp_STDEV,ViralLoad_Hosp_LowRange,ViralLoad_Hosp_UpRange,ViralLoad_Hosp_Median,ViralLoad_Hosp_Q1,ViralLoad_Hosp_Q3,ViralLoad_Hosp_Unit,ViralLoad_Nonhosp_N,ViralLoad_Nonhosp_Mean,ViralLoad_Nonhosp_STDEV,ViralLoad_Nonhosp_LowRange,ViralLoad_Nonhosp_UpRange,ViralLoad_Nonhosp_Median,ViralLoad_Nonhosp_Q1,ViralLoad_Nonhosp_Q3,ViralLoad_Nonhosp_Unit,ViralLoad_Intub_N,ViralLoad_Intub_Mean,ViralLoad_Intub_STDEV,ViralLoad_Intub_LowRange,ViralLoad_Intub_UpRange,ViralLoad_Intub_Median,ViralLoad_Intub_Q1,ViralLoad_Intub_Q3,ViralLoad_Intub_Unit,ViralLoad_Nonintub_N,ViralLoad_Nonintub_Mean,ViralLoad_Nonintub_STDEV,ViralLoad_Nonintub_LowRange,ViralLoad_Nonintub_UpRange,ViralLoad_Nonintub_Median,ViralLoad_Nonintub_Q1,ViralLoad_Nonintub_Q3,ViralLoad_Nonintub_Unit,ViralLoad_Mortality_N,ViralLoad_Mortality_Mean,ViralLoad_Mortality_STDEV,ViralLoad_Mortality_LowRange,ViralLoad_Mortality_UpRange,ViralLoad_Mortality_Median,ViralLoad_Mortality_Q1,ViralLoad_Mortality_Q3,ViralLoad_Mortality_Unit,ViralLoad_Survived_N,ViralLoad_Survived_Mean,ViralLoad_Survived_STDEV,ViralLoad_Survived_LowRange,ViralLoad_Survived_UpRange,ViralLoad_Survived_Median,ViralLoad_Survived_Q1,ViralLoad_Survived_Q3,ViralLoad_Survived_Unit,ViralLoad_Other,ViralLoad_Other_N,ViralLoad_Other_Mean,ViralLoad_Other_STDEV,ViralLoad_Other_LowRange,ViralLoad_Other_UpRange,ViralLoad_Other_Median,ViralLoad_Other_Q1,ViralLoad_Other_Q3,ViralLoad_Other_Unit,Abbrevation,Author,_merge
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,.,,,,,,,,.,.,,,,,,,,.,.,,,,,,,,.,.,,,,,,,,.,.,,,,,,,,.,.,,,,,,,,.,.,,,,,,,,.,.,,,,,,,,.,,.,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,master only (1)
13aug2020 00:44:53,2ETNH7WX,SaK,Selective CD8 cell reduction by SARS-CoV-2 is associated with a worse prognosis and  systemic inflammation in COVID-19 patients.,Peer reviewed,Spain,Single center, case-control study,Upon hospitalization,Retrospective,  3/1/2020, 4/15/2020,ICU admission,172,172,172,,,,,,68,upper respiratory tract,27,,,,,,,,,.,.,.,145,,,,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,27,7,65.64,14.1,,,,.,.,,,145,61,57.89,13.1,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,27,152,90,,,,,,mg/L,145,104,80,,,,,,mg/L,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,decreased (<500 cells/mm3),340.3,251.9,,,,,,/µL,decreased (<500 cells/mm3),395.9,241,,,,,,/µL,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,.,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,Clin Imm.,"Urra, J. M. (Clin Imm.)",matched (3)
15jul2020 21:11:19,2V8JLGX7,SK,"The experience of high-flow nasal cannula in hospitalized patients with 2019 novel coronavirus-infected pneumonia in two hospitals of Chongqing, China.",Peer reviewed,China,Multi center,Cohort study,Upon hospitalization,Retrospective,  1/1/2020,  3/4/2020,Hospitalization,318,27,17,,,65,56,75,59,throat swab,,,,,,,,,,.,.,.,,,,,,,,.,,,,17,10,,,65,56,75,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,2,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,17,,,,,39,22,67,mg/L,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,17,,,,,.07,.06,.09,ng/mL,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,A. Int. C.,"Wang, Ke (A. Int. C.)",matched (3)
15aug2020 14:10:50,35Y57TTG,AM,Clinical impact of pre-admission antithrombotic therapy in hospitalized patients  with COVID-19: A multicenter observational study.,Peer reviewed,Italy,Multi center,Cohort study,Upon hospitalization,Retrospective,  2/1/2020,  4/1/2020,Mortality,963,192,192,67.7,15.2,,,,40.1,nose/throat swab or sputum samplenose,35,15,77,8.300000000000001,,,,18.22,,.,.,.,157,62,65.59999999999999,15.6,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,PHRS,"Russo, Vincenzo (PHRS)",matched (3)
09aug2020 16:55:32,3B6JV5B8,MG,Factors associated with hospital admission and critical illness among 5279 people  with coronavirus disease 2019 in New York City: prospective cohort study.,Peer reviewed,United States,Multi center,Cohort study,Presentation at Emergency department,Prospective,  3/1/2020,  4/8/2020,"Hospitalization, ICU admission, Invasive mechanical ventilation, Mortality",11544,5279,5279,,,54,38,66,51.5,nasopharyngeal or oropharyngeal swab,,,,,,,,,,.,.,.,,,,,,,,.,,,,2741,1063,,,63,51,74,,,,",8100000000000001",2538,1601,,,42,32,55,,,,,990,335,,,68,58,78,.,.,.5649999999999999,.57,1739,723,,,60,48,71,,,,,647,,,,,,,,,.,.,2100,,,,,,,,,,,.,,,.,,948,,,,,136.3,85.8,204.2,mg/L,1616,,,,,89.09999999999999,41.9,148,mg/L,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,946,,,,,.27,.12,.82,ng/mL,1592,,,,,.1,.05,.23,ng/mL,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,BMJ,"Petrilli, Christopher M. (BMJ)",matched (3)
05jul2020 10:07:59,3CKPAER3,CG,"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.",Peer reviewed,China,Single center,Cohort study,ICU admission,Retrospective, 12/1/2019, 1/26/2020,Mortality,710,201,52,59.7,13.3,,,,17,not specified,32,11,64.59999999999999,11.2,,,,,,28-day mortality,.,.,20,6,51.9,12.9,,,,28-day mortality,,,,,,,,,,,,,,.,,,,,,,,,,,,52,17,59.7,13.3,,,,.,28-day mortality,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,Lancet,"Yang, Xiaobo (Lancet)",matched (3)
12aug2020 01:26:14,3KUJH3M9,SaK,Smell and taste alterations in COVID-19: a cross-sectional analysis of different  cohorts.,Peer reviewed,Italy,Multi center,Cross-sectional study,conﬁrmed infection for SARS-CoV-2 ,Prospective, 3/27/2020,  4/1/2020,Hospitalization,575,508,508,55,15,,,,44,nasal/pharyngeal swab,,,,,,,,,,.,.,.,,,,,,,,.,,,,295,91,61.9,12.8,,,,,,,.,213,132,44.7,12.1,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,ALR,"Paderno, Alberto (ALR)",matched (3)
15aug2020 13:10:44,3LSGJJ58-DIAB,AM,"Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With  Diabetes in Wuhan, China: A Two-Center, Retrospective Study.",Peer reviewed,China,Multi center,Cohort study,death or discharge,Retrospective,  1/1/2020,  3/8/2020,Mortality,1561,153,153,,,65,56,72,51,throat swab,31,9,,,76,65,82,20.26,,.,.,.,122,69,,,63,56,69,.,,,,,,,,,,,,,,.,,,,,,,,,,,,27,,,,,,,.,.,,,126,,,,,,,,,,,11,,,,,,,,,.,.,142,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,31,,,0,10,85.5,45.4,170,mg/L,122,,,0,10,11.6,5,62.5,mg/L,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,31,,,0,.1,.47,.15,1.4,ng/mL,122,,,0,.1,.05,.04,.1,ng/mL,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,decreased (<500 cells/mm3),,,404,1612,130,103,277,/µL,normal (500-1400 cells/mm3),,,404,1612,442.5,264.5,676,/µL,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,DC,"Shi, Qiao (DC) Diabetic cohort",matched (3)
15aug2020 13:16:14,3LSGJJ58-NONDIAB,AM,"Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With  Diabetes in Wuhan, China: A Two-Center, Retrospective Study.",Peer reviewed,China,Multi center,Cohort study,death or discharge,Retrospective,  1/1/2020,  3/8/2020,Mortality,1561,153,153,,,64,56,72,51,throat swab,16,10,,,72,68,81,,,.,.,.,137,68,,,63,56,70,.,,,,,,,,,,,,,,.,,,,,,,,,,,,12,,,,,,,.,.,,,141,,,,,,,,,,,4,,,,,,,,,.,.,149,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,16,,,0,10,115.2,34.3,192.2,mg/L,137,,,0,10,10.8,5,47.4,mg/L,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,16,,,0,.1,.14,.1,.48,ng/mL,137,,,0,.1,.05,.04,.07,ng/mL,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,decreased (<500 cells/mm3),,,404,1612,130.5,92,369.8,/µL,normal (500-1400 cells/mm3),,,404,1612,396,293,599,/µL,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,"Shi, Qiao (DC) Non-diabetic cohort",matched (3)
06aug2020 10:22:52,3TIPE78H,SS,Correlation between Chest Computed Tomography Scan Findings and Mortality of,Peer reviewed,Iran,Single center,Cross-sectional study,admission to emergency department,Retrospective, 2/22/2020, 3/22/2020,Mortality,380,380,380,53.57,16.66,,,,33.9,#,29,7,63.6,17.68,,,,7.6,,.,.,.,351,122,52.85,16.35,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,29,89.89,68.70999999999999,,,,,,mg/L,351,46.47,42.77,,,,,,mg/L,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,.,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,Arch. Aca EM,"Raoufi, Masoomeh (Arch. Aca EM)",matched (3)
04jul2020 19:27:39,435U4F4F,CG,"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China",Peer reviewed,China,Single center,Cohort study,Upon hospitalization,Retrospective,12/16/2019,  1/2/2020,ICU admission,59,59,41,,,49,41,58,27,respiratory specimens,6,,,,,,,,,.,.,.,35,,,,,,,.,,,,41,,,,,,,,,,.,34,,,,,,,,,,,13,2,,,49,41,61,.,.,,,28,9,,,49,41,57.5,,,,,2,,,,,,,,,.,.,39,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,12,,,,,.1,.1,.4,ng/mL,27,,,,,.1,.1,.1,ng/mL,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,13,,,,,31.1,30,33.5,Cycle threshold of respiratory tract ,28,,,,,32.2,31.1,34.7,Cycle threshold of respiratory tract,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,Lancet,"Huang, Chaolin (Lancet)",matched (3)
22aug2020 11:55:24,4BANTYXG,MG,Prognostic value of C-reactive protein in patients with COVID-19.,Pre-print,China,Single center,Cohort study,Upon hospitalization,Retrospective, 1/30/2020, 2/20/2020,Mortality,298,298,298,,,57,40,69,49.7,NA,84,33,,,71,64,80,,,,.,.,214,115,,,51,37,63,,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,84,,,,,100,60.7,179.4,mg/L,214,,,,,9.65,5,37.9,mg/L,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,84,,,,,.228,.119,.991,ng/mL,214,,,,,.043,.027,.065,ng/mL,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,CID,"Luo, Xiaomin (CID)",matched (3)
08aug2020 20:20:05,4BLN5IPX,MG,Characteristics of Emergency Department Patients With COVID-19 at a Single Site in  Northern California: Clinical Observations and Public Health Implications.,Peer reviewed,United States,Single center,Cross-sectional study,Emergency Department Admisssions,Retrospective,  3/4/2020, 9/23/2020,"Hospitalization, ICU admission, Invasive mechanical ventilation, Mortality",1468,100,100,,,45,32,65,44,nasopharygnal swaps,1,,82,,,,,,,,.,.,99,,,,,,,.,,,,24,11,,,64,44,74,,,,.,76,33,,,42,31,59,,,,,6,,,,65,,,.,.,,,18,,,,,,,,,,,4,,,,,,,,,.,.,20,,,,,,,,,,,,,,,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,ACEM,"Duanmu, Youyou (ACEM)",matched (3)
15aug2020 15:41:45,56SZ2NIV,AM,Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for  intensive care unit admission of COVID-19 patients.,Peer reviewed,France,Single center,Cohort study,Upon hospitalization,Prospective,  1/1/2000,12/31/2000,ICU admission,40,40,40,,,,,,30,nasopharyngeal swab,,,,,,,,,,.,.,.,,,,,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,20,3,,,59.5,54.25,70.5,.,.,,,20,9,,,53,37,65.40000000000001,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,20,,,,,146,101.3,204.8,mg/L,20,,,,,76.8,31.9,101.2,mg/L,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,Angiogenesis,"Smadja, David M. (Angiogenesis)",matched (3)
22aug2020 11:51:41,5HTSBVYA,CG,Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.,Peer reviewed,China,Single center,Cohort study,Hospitalized Severe Patients (Subset of hospitalized patients),Retrospective,  1/1/2020, 2/13/2020,Mortality,1786,449,449,65.09999999999999,12,,,,40.3,not specified,134,44,68.7,11.4,,,,,,.,.,given for multiple factors,315,137,63.7,12.2,,,,.,,,,449,181,65.09999999999999,12,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,JTH,"Tang, Ning (JTH, 02/20)",matched (3)
25jun2020 13:27:31,5LBSZSE5,SK,Coronavirus Disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up.,Peer reviewed,China,Single center,Cohort study,Upon hospitalization,Retrospective,  1/1/2020,  3/5/2020,Mortality,339,339,339,,,69,65,76,51,throat swab,65,26,,,76,70,83,,,.,.,.,274,147,,,68,64,74,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,65,,,,,102,58.9,187.4,mg/L,274,,,,,44.2,13.5,82.2,mg/L,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,65,,,,,.22,.11,1.13,ng/mL,274,,,,,.06,.04,.13,ng/mL,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,65,,,,,93.8,35.9,182.3,pg/mL,274,,,,,10.5,4.9,18.8,pg/mL,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,decreased (<500 cells/mm3),,,,,191,107,282,/µL,decreased (<500 cells/mm3),,,,,349,217,516,/µL,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,J. Inf.,"Wang, Lang (J. Inf.)",matched (3)
16aug2020 15:58:41,69F93R7V,SS,Renin-Angiotensin-Aldosterone System Inhibitors and Outcome in Patients With,Peer reviewed,Italy,Single center,Cohort study,Upon hospitalization,Retrospective, 2/27/2020, 3/17/2020,Mortality,212,191,191,,,,,,31.4,#,42,11,75.3,12.9,,,,28.18,,.,for most parameters,.,149,49,60.4,13.7,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,42,134,84.90000000000001,,,,,,mg/L,149,93.7,71.90000000000001,,,,,,mg/L,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,Hypertension,"Andrea, Conversano (Hypertension)",matched (3)
09aug2020 19:32:56,6S8JAYKB,MG,Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to  Intensive Care Unit in South of France.,Peer reviewed,France,Single center,Cohort study,ICU admission,Retrospective, 3/10/2020, 4/21/2020,"ICU admission, Invasive mechanical ventilation, Mortality",96,96,96,63.4,,,,,20.3,nasopharygnal ,9,,68,,,,,,,.,.,.,87,17,,,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,71,14,63.4,,,,,,,.,.,20,6,63.8,,,,,,,,,,,,,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,.,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,Therapie,"Montastruc, François (Therapie)",matched (3)
12jul2020 14:56:59,79A39G2V,CG,"Clinical Features and Short-term Outcomes of 102 Patients with Corona Virus Disease 2019 in Wuhan, China.",Peer reviewed,China,Single center,Cohort study,Upon hospitalization,not stated,  1/3/2020,  2/1/2020,Mortality,0,104,102,,,54,37,67,48,throat swab,17,4,,,72,63,81,,,.,.,.,85,45,,,53,47,66,.,,,,,,,,,,,,,,.,,,,,,,,,,,,18,,,,,,,.,.,,,84,,,,,,,,,,,14,,,,,,,,,.,.,88,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,17,,,,,118.8,39.9,160,mg/L,102,,,,,24.8,6.7,55.7,mg/L,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,CID,"Cao, Jianlei (CID)",matched (3)
17aug2020 01:21:51,7CAQ5CRL,SaK,Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019-Induced Acute  Respiratory Distress Syndrome: A Multicenter Descriptive Study.,Peer reviewed,China,Multi center,Cohort study,ICU admission,Retrospective,  1/8/2020, 3/31/2020,Mortality,59,59,59,,,65.5,56.75,76,19,#,12,,,,,,,,,.,.,.,9,,,,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,12,,,,,.19,.07,1.39,ng/mL,9,,,,,.36,.06,3.53,ng/mL,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,CCM,"Yang, Xia (CCM)",matched (3)
16aug2020 15:37:47,7N2BBLB7,SS,"Characteristics of patients with COVID-19 pneumonia at Hvidovre Hospital,  March-April 2020.",Peer reviewed,Denmark,Single center,Cohort study,Upon hospitalization,Retrospective, 3/10/2020, 4/23/2020,ICU admission,175,175,175,,,71,55,81,51.4,oropharyngeal swab or a lower respiratory tract specimen,,,,,,,,,,.,.,.,,,,,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,27,11,,,68,60,72,.,.,,,148,79,,,73,55,83,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,,,27,,,,,130,72,180,mg/L,148,,,,,56,29,120,mg/L,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,.,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,DMJ,"Israelsen, Simone B. (DMJ)",matched (3)
13aug2020 19:33:04,7NCLBD3R,MG,30-day mortality in patients hospitalized with COVID-19 during the first wave of the  Italian epidemic: A prospective cohort study.,Peer reviewed,Italy,Single center,Cohort study,Upon hospitalization,Prospective, 2/21/2020, 3/19/2020,"Invasive mechanical ventilation, Mortality",233,233,233,,,61,50,72,72,nasopharygnal swaps,48,9,,,,,,,,.,.,.,185,63,,,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,8,,,,,,,,,.,.,225,,,,,,,,,,,,,,,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,48,,,,,130,40,203.5,mg/L,185,,,,,40.9,17.9,102,mg/L,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,.,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,PHRS,"Giacomelli, Andrea (PHRS)",matched (3)
15aug2020 07:33:31,997WN4TG,SS,COVID-19: clinical course and outcomes of 36 hemodialysis patients in Spain.,Peer reviewed,Spain,Single center,Cohort study,hospitalyzed hemodialysis patients,Retrospective, 3/12/2020, 4/10/2020,Mortality,36,36,36,71,12,,,,36,#,11,5,75,6,,,,30.55,,.,yes for most parameters,.,25,8,69,14,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,11,74,43,,,,,,mg/L,25,103,83,,,,,,mg/L,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,11,,,,,.52,.19,2.49,ng/mL,25,,,,,.4,.21,.86,ng/mL,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,KINT,"Goicoechea, Marian (KINT)",matched (3)
16aug2020 15:56:40,9EUL6LCD,SS,Chest X-ray severity index as a predictor of in-hospital mortality in coronavirus  disease 2019: A study of 302 patients from Italy.,Peer reviewed,Italy,Multi center,Cohort study,Upon hospitalization,Retrospective,  3/4/2020, 3/24/2020,Mortality,302,302,302,,,67,57,77,35.8,#,65,15,,,77,70.5,81,21.5,,.,.,"for brixia score, age, immunosuppression",237,93,,,64,54,73.3,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,.,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,IJID,"Borghesi, Andrea (IJID)",matched (3)
17jul2020 16:48:26,9PRP5X7J,SK,"Clinical Characteristics of 54 medical staff with COVID-19: A retrospective study in a single center in Wuhan, China.",Peer reviewed,China,Single center,Cohort study,Upon hospitalization,Retrospective,  1/7/2020, 2/11/2020,Hospitalization,54,54,54,,,39,26,73,33.3,throat swab,,,,,,,,,,.,.,.,,,,,,,,.,,,,54,18,,,39,26,73,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,JMV,"Chu, Jiaojiao (JMV)",matched (3)
11jul2020 21:50:32,9WK7M6VV,SK,Evaluation of the clinical characteristics of suspected or confirmed cases of COVID-19 during home care with isolation: A new retrospective analysis based on O2O,Pre-print,China,Single center,Cohort study,Upon hospitalization,Retrospective,  1/6/2020, 1/31/2020,Hospitalization,188,74,48,39.08,13.88,,,,72.90000000000001,throat swab,,,,,,,,,,.,.,.,,,,,,,,.,,,,6,3,54,18.61,,,,,,,.,42,32,36.93,11.57,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,Preprint,"Xu, Hui  (Preprint)",matched (3)
16aug2020 15:55:42,9ZS9ANWF,SS,Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care  unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment  hospitalisation status.,Peer reviewed,Italy,Single center,Cohort study,Upon hospitalization,Prospective, 2/23/2020, 3/20/2020,ICU admission,50,48,35,,,63,51,69,24.7,#,,,,,,,,,,.,.,.,,,,,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,18,14,,,60.5,49.2,63.7,.,.,,,17,5,,,64,51,75,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,18,,,,,177,57,311,mg/L,17,,,,,106,55,185,mg/L,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,.,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,PHRS,"Antinori, Spinello (PHRS)",matched (3)
12jul2020 17:30:20,9ZZKBBU6,SK,"Clinical findings in critical ill patients infected with SARS-Cov-2 in Guangdong Province, China: a multi-center, retrospective, observational study",Pre-print,China,Multi center,Cohort study,ICU admission,Retrospective, 1/14/2020, 2/20/2020,Invasive mechanical ventilation,45,45,45,56.7,15.4,,,,35.6,throat swab,,,,,,,,,,.,.,.,,,,,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,20,6,62.1,13.56,,,,,,.,.,25,10,52.4,15.7,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,20,,,,,.4,.1,2.9,ng/mL,25,,,,,.1,.1,.1,ng/mL,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,Preprint,"Xu, Yonghao (Preprint)",matched (3)
28jun2020 17:34:21,A7QM33KJ,SK,Comparison of Hospitalized Patients with Acute Respiratory Distress Syndrome Caused by COVID-19 and H1N1.,Peer reviewed,China,Single center,Cohort study,ICU admission,Retrospective,12/24/2019,  2/7/2020,ICU admission,179,73,73,,,67,57,72,38.4,throat swab,21,,,,,,,,,.,.,.,26,,,,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,73,28,,,67,57,72,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,73,,,,,.1,0,.24,ng/mL,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,97,57,194,/µL,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,Chest,"Tang, Xiao (Chest)",matched (3)
12aug2020 21:20:07,ABIBUNQ8,SaK,Obesity predisposes to the risk of higher mortality in young COVID-19 patients.,Peer reviewed,China,Multi center,Cohort study,Upon hospitalization,Retrospective,  2/7/2020, 3/27/2020,Mortality,3954,53,53,,,,,,,NA,13,,,,,,,,,.,.,.,40,,,,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,13,,,,,58.4,51.45,141.25,mg/L,40,,,,,13.05,4.7,47.68,mg/L,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,7,,,,,22.88,18.9,27.76,pg/mL,27,,,,,9.5,1.79,18.09,pg/mL,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,JMV,"Zhang, Fengqin (JMV)",matched (3)
14jul2020 21:34:47,ACVD9QCM,CG,"Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.",Peer reviewed,China,Single center,Cohort study,Upon hospitalization,Retrospective,12/25/2019, 1/26/2020,ARDS or No ARDS / Mortality in patients with ARDS,201,201,201,,,51,43,60,73,throat swab,44,15,,,68.5,59.3,75,,,.,.,.,40,9,,,50,40.3,56.8,.,,,,201,73,,,51,43,60,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,44,,,,,10.07,7.36,14.8,pg/mL,40,,,,,6.05,5.12,6.99,pg/mL,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,166,128.5,312.5,/µL,NA,,,,,286,132,449.5,/µL,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,JAMA intern,"Wu, Chaomin (JAMA intern)",matched (3)
22jul2020 21:35:30,B5KHHL2W,SK,"Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China.",Peer reviewed,China,Single center,Cohort study,Upon hospitalization,Retrospective, 1/16/2020,  2/4/2020,Hospitalization,69,69,69,,,42,35,62,54,throat swab,5,,,,,,,,,.,.,.,18,,,,,,,.,,,,69,37,,,42,35,62,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,69,,,,,13.2,6.78,49,mg/L,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,69,,,,,.13,.13,.15,ng/mL,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,43,,,,,8.539999999999999,4.68,20.58,pg/mL,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,CID,"Wang, Zhongliang (CID)",matched (3)
07aug2020 16:19:10,BH7668EU,SaK,"Clinical Features and Outcomes of 98 Patients Hospitalized with SARS-CoV-2 Infection  in Daegu, South Korea: A Brief Descriptive Study.",Peer reviewed,South Korea,Single center,Cohort study,Upon hospitalization,Retrospective,1/1/1000, 3/29/2020,ICU admission,98,98,98,55.4,17.1,,,,61.2,NA,5,,,,,,,,,.,.,.,93,,,,,,,.,,,,98,60,55.4,17.1,,,,,,,.,,,,,,,,,,,,13,7,63.2,10.1,,,,.,.,,,85,53,54.2,17.7,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,13,177,95,,,,,,mg/L,85,42,67,,,,,,mg/L,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,13,2.7,7,,,,,,ng/mL,85,.2,1.3,,,,,,ng/mL,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,YMJ,"Hong, Kyung Soo (YMJ)",matched (3)
12aug2020 12:40:40,BJEBXVJ2,SaK,Hypoalbuminemia predicts the outcome of COVID-19 independent of age and  co-morbidity.,Peer reviewed,China,Single center,Cohort study,Upon hospitalization,Retrospective, 1/25/2020, 3/24/2020,Mortality,299,299,299,53.4,16.7,,,,46.5,naso-pharyngeal swab ,16,5,69.2,9.699999999999999,,,,,,.,.,.,283,134,52.5,16.6,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,46,,,,,,,.,.,,,253,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,16,53.5,47.7,,,,,,mg/L,283,24.7,33.2,,,,,,mg/L,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,16,.3,.3,,,,,,ng/mL,283,.2,.6,,,,,,ng/mL,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,JMV,"Huang, Jiaofeng (JMV)",matched (3)
16aug2020 16:00:27,BMCVQU9G,SS,Characteristics associated with hospitalisation for COVID-19 in people with  rheumatic disease: data from the COVID-19 Global Rheumatology Alliance  physician-reported registry.,Peer reviewed,Australia,Multi center,Cross-sectional study,COVID-19 Global Rheumatology Alliance registry,Retrospective, 3/24/2020, 4/20/2020,Hospitalization,604,600,600,,,56,45,67,71,#,,,,,,,,,,.,.,.,,,,,,,,.,,,,277,185,,,62,51,71,,,,"for rheumatic diseases, comorbidities and medication ",323,238,,,52,42,60,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,AnnRheumDis,"Gianfrancesco, Milena (AnnRheumDis)",matched (3)
09jul2020 18:30:29,BPR7A47M,SK,Radiographic Findings and other Predictors in Adults with Covid-19,Pre-print,China,Single center,Cohort study,Upon hospitalization,Retrospective, 1/31/2020,  3/5/2020,Mortality,128,102,102,,,57,45,70,42,throat swab,15,4,,,69,58,77,,,.,.,.,87,39,,,55,44,66,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,15,,,0,1,78.7,51.3,166.3,mg/L,87,,,0,1,25.4,3.9,81.3,mg/L,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,15,,,0,.05,.19,.12,.6,ng/mL,87,,,0,.05,.05,.03,.1,ng/mL,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,15,,,0,7,48.4,12.6,154.1,pg/mL,87,,,0,7,4.2,1.9,16.4,pg/mL,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,0,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,Preprint,"Li, Kaiyan (Preprint)",matched (3)
05aug2020 15:55:42,BQ2FZA7C,AM,Clinical Characteristics and Progression of 2019 Novel Coronavirus-Infected Patients Concurrent Acute Respiratory Distress Syndrome,Pre-print,China,Single center,Cohort study,Upon hospitalization,Retrospective,  1/2/2020,  2/1/2020,"ICU admission, Mortality, development of ARDS ",0,109,109,55,,55,43,66,45.9,throat swab,31,,,,,,,,,.,.,.,78,,,,,,,.,,,,109,50,50,,,43,66,,,,.,,,,,,,,,,,,53,25,61,,,52,70,.,.,,,56,25,49,,,37,59,,,,,,,,,,,,,,.,.,,,,,,,,,,,,high-flow nasal ventilation; 28 ,,,.,,53,,,0,5,49,27,65,mg/L,56,,,0,5,20,9,32,mg/L,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,53,,,0,.05,.15,.08,.37,ng/mL,56,,,0,.05,.06,.05,.09,ng/mL,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,Preprint,"Liu, Yanli (Preprint)",matched (3)
16aug2020 15:34:53,CENJBEAA,SS,Presentation and Outcomes of Patients with ESKD and COVID-19.,Peer reviewed,United States,Single center,Cohort study,patients with ESKD on dialysis admitted to hospital,Retrospective,  3/9/2020,  4/2/2020,"Invasive mechanical ventilation, Mortality",59,59,59,,,63,56,78,44,nasopharyngeal swabs,18,8,,,75,61,81,31,,.,.,.,41,18,,,62,54,73,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,8,6,,,65,58,79,,,.,.,40,16,,,62,54,73,,,,,,,,,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,163,78.09999999999999,298,mg/L,,,,,,80.3,19.6,116,mg/L,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,2.04,1.28,13.82,ng/mL,,,,,,1.71,.72,3.05,ng/mL,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,.,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,ASN,"Valeri, Anthony M. (ASN)",matched (3)
30jun2020 21:03:36,CF7TME72,SK,Timely Diagnosis and Treatment Shortens the Time to Resolution of Coronavirus Disease (COVID-19) Pneumonia and Lowers the Highest and Last CT Scores From Sequential Chest CT.,Peer reviewed,China,Single center,Cohort study,Upon hospitalization,Retrospective, 1/22/2020, 2/28/2020,Hospitalization,33,30,25,46.9,15.8,,,,44,throat swab,,,,,,,,,,.,.,.,,,,,,,,.,,,,25,11,46.9,15.8,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,25,36.8,44.9,,,,,,mg/L,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,AJR,"Huang, Guoquan (AJR)",matched (3)
10aug2020 18:38:31,CSTFV4PS,SaK,"The clinical data from 19 critically ill patients with coronavirus disease 2019: a  single-centered, retrospective, observational study.",Peer reviewed,China,Single center,Cohort study,ICU admission,Retrospective, 1/16/2020, 2/20/2020,Mortality,19,19,19,,,73,,,42.1,#,8,3,,,77,,,,,.,.,.,11,5,,,68,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,Journ. Pub. Health,"Zhang, Jinping (Journ. Pub. Health)",matched (3)
07aug2020 11:31:27,CU9AYGFS,SaK,Clinical characteristics and outcomes of patients undergoing surgeries during the  incubation period of COVID-19 infection.,Peer reviewed,China,Multi center,Cohort study,Upon hospitalization,Retrospective,  1/1/2020,  2/5/2020,ICU admission,37,34,34,,,55,43,63,58.8,respiratory tract,7,4,,,55,48,77,20.6,,,.,.,27,16,,,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,15,10,,,55,44,74,.,.,,,19,10,,,47,29,58,,,,,5,,,,,,,,,.,.,25,,,,,,,,,,,.,,,.,,15,,,,,29.6,12.5,86.59999999999999,mg/L,19,,,,,24.8,7.7,72.3,mg/L,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,EClinM,"Lei, Shaoqing (EClinM)",matched (3)
22aug2020 11:53:05,DAZ9MEWV,AM,Comparing Rapid Scoring Systems in Mortality Prediction of Critically Ill Patients  With Novel Coronavirus Disease.,Peer reviewed,China,Single center,Cohort study, critically ill COVID-19 patients admitted to  COVID-19 ward,Retrospective,  2/7/2020,  3/7/2020,Mortality,138,138,105,60.82,16.32,,,,40.95,#,19,5,75.05,12.94,,,,,,.,.,.,86,38,57.71,15.34,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,ACEM,"Hu, Hai (ACEM)",matched (3)
15aug2020 11:07:35,DNNPPKQN,SS,COVID-19 mortality in patients with cancer on chemotherapy or other anticancer  treatments: a prospective cohort study.,Peer reviewed,United Kingdom,Multi center,Cohort study,UK Coronavirus Cancer Monitoring Project database,Prospective, 3/18/2020, 4/26/2020,Mortality,800,800,800,,,69,59,76,44,throat or nose swab,226,80,,,73,66,80,28.25,,.,.,for all parameters,574,269,,,66,57,74,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,Lancet,"Lee, Lennard Y. W. (Lancet)",matched (3)
22aug2020 11:52:22,E2DP6GPS,CG,"Association of radiologic findings with mortality of patients infected with 2019  novel coronavirus in Wuhan, China.",Peer reviewed,China,Single center,Cohort study,Upon hospitalization,Retrospective,  1/1/2020, 1/25/2020,Mortality,27,27,27,,,60,47,69,55,throat swab,10,6,,,68,63,73,,,.,.,.,17,9,,,55,35,60,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,PloS one,"Yuan, Mingli (PloS one)",matched (3)
11jul2020 22:57:24,EFSV3N8U,SK,"Myocardial injury is associated with in-hospital mortality of confirmed or suspected COVID-19 in Wuhan, China: A single center retrospective cohort study",Pre-print,China,Single center,Cohort study,Upon hospitalization,Retrospective,12/25/2019, 2/15/2020,Mortality,110,64,48,70.58,13.38,,,,31.3,throat swab,17,5,78.65000000000001,8.31,,,,,,.,.,.,31,10,66.16,13.66,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,17,,,,,65.5,46.4,125.9,mg/L,27,,,,,23.8,15.3,87.59999999999999,mg/L,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,Preprint,"Zhang, Fan  (Preprint)",matched (3)
15jul2020 21:54:34,EGMSS6WE,SK,"Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China.",Peer reviewed,China,Multi center,Cohort study,Upon hospitalization,Retrospective, 1/13/2020, 2/26/2020,"Hospitalization, ICU admission, Mortality",1276,28,28,,,65,56,70,29.3,throat swab,8,,,,,,,,,.,.,.,,,,,,,,.,,,,28,11,,,65,56,70,,,,.,,,,,,,,,,,,6,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,28,,,0,5,60.6,8.5,101.2,mg/L,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,28,,,0,.5,.1,0,.3,ng/mL,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,10,,,0,7,62.6,17.6,168,pg/mL,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,J. Annonc.,"Zhang, L. (J. Annonc.)",matched (3)
09aug2020 10:38:12,EKNW9JZ6,AM,"Covid-19 Testing, Hospital Admission, and Intensive Care Among 2,026,227 United  States Veterans Aged 54-75 Years.",Pre-print,United States,Multi center,Cohort study,"veterans aged 54-75 years, tested for Covid-19 between",Retrospective,  2/8/2020, 3/30/2020,"Hospitalization, ICU admission",2026227,3789,585,,,66.09999999999999,60.4,71,4.6,99 % nasopharyngeal; remaining 1 % NA,17,,,,,,,,,.,.,.,568,,,,,,,.,,,,297,8,,,67.59999999999999,61.7,71.59999999999999,,,,.,288,19,,,64.5,59.7,70.5,,,,,122,3,,,69.90000000000001,64.40000000000001,71.7,.,.,,,463,24,,,64.7,59.8,70.8,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,Preprint,"Rentsch, Christopher T. (Preprint)",matched (3)
21jun2020 14:34:17,EN3559Q5,CG,Clinical characteristics of 113 deceased patients with coronavirus disease 2019:  retrospective study.,Peer reviewed,China,Single center,Cohort study,Upon hospitalization,Retrospective, 1/13/2020, 2/12/2020,Mortality,799,274,274,,,62,44,70,38,throat swab,113,30,,,68,62,77,,,.,.,.,161,73,,,51,37,66,.,,,,274,103,,,62,44,70,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,17,,,,,,,,,.,.,257,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,274,,,,,53.4,18.6,113,mg/L,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,113,,,,,113,69.09999999999999,168.4,mg/L,161,,,,,26.2,8.699999999999999,55.8,mg/L,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,274,,,,,.09,.04,.23,ng/mL,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,113,,,,,.33,.14,.65,ng/mL,161,,,,,.05,.03,.08,ng/mL,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,274,,,,,22,6.1,51.8,pg/mL,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,113,,,,,72,35.6,146.8,pg/mL,161,,,,,13,4,26.2,pg/mL,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,BMJ,"Chen, Tao (BMJ)",matched (3)
15aug2020 06:30:17,ETHYZ3WX,SS,"Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou,  China.",Peer reviewed,China,Multi center,Cohort study,In the community,Retrospective, 1/19/2020, 2/20/2020,ICU admission,116,27,27,,,62,53,71,33.3,nasal and pharyngeal swab,,,,,,,,,,.,.,.,,,,,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,9,3,,,71,60.5,80.5,.,.,,,18,6,,,57,47.5,67.8,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,CCA,"Sun, Suyu (CCA)",matched (3)
13aug2020 09:49:47,EVPJ4R78,MG,Clinicolaboratory study of 25 fatal cases of COVID-19 in Wuhan.,Peer reviewed,China,Single center,Cohort study,Upon hospitalization,Retrospective,  1/3/2020, 2/24/2020,"ICU admission, Invasive mechanical ventilation, Mortality",174,174,174,,,,,,79,throat swaps,25,6,,,70,64,80,14.4,,.,.,.,149,89,,,51,37,62,,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,19,,,,,,,,,.,.,155,,,,,,,,,,,,,,,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,25,,,,25,118,22,184,mg/L,149,,,,25,22,6,45,mg/L,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,25,,,,,108.8,44.1,177.9,pg/mL,149,,,,,16.8,4.4,76.90000000000001,pg/mL,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,.,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,Int. Care Med.,"Tu, Wen-Jun (Int. Care Med.)",matched (3)
15aug2020 13:26:54,F4EQ849U,SaK,ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease  2019.,Peer reviewed,United States,Multi center,Cohort study,ICU admission,Retrospective,  3/6/2020, 4/17/2020,Mortality,217,217,217,,,64,54,73,98,#,67,,,,,,,,,.,.,.,131,,,,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,165,,,,,,,,,.,.,52,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,62,,,,,197,160,281,mg/L,147,,,,,182,119,248,mg/L,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,CCM,"Auld, Sara C. (CCM)",matched (3)
16aug2020 15:51:31,FDTKE52S,SS,"Risk Factors for Mortality in 244 Older Adults With COVID-19 in Wuhan, China: A  Retrospective Study.",Peer reviewed,China,Single center,Cohort study,Upon hospitalization,Retrospective, 1/29/2020,  3/5/2020,Mortality,244,244,244,,,,,,45.5,#,121,39,,,72,66,78,49.6,,.,.,for most factors,123,72,,,67,64,72,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,121,,,,,105.4,65,165.2,mg/L,123,,,,,39.8,8.300000000000001,79.59999999999999,mg/L,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,121,,,,,.36,.14,1.01,ng/mL,123,,,,,.05,.03,.09,ng/mL,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,121,,,,,75.2,35.2,162.9,pg/mL,123,,,,,12.7,3.3,41.5,pg/mL,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,JGS,"Sun, Haiying (JGS)",matched (3)
25jun2020 22:20:23,FNSYSATA,SK,Diabetes is a risk factor for the progression and prognosis of COVID-19.,Peer reviewed,China,Single center,Cohort study,Upon hospitalization,Retrospective, 2/10/2020, 2/29/2020,Hospitalization,174,174,174,,,59,49,67,56.3,throat swab,,,,,,,,,,.,.,.,,,,,,,,.,,,,174,98,,,59,49,67,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,174,,,,,17.7,7.34,51.8,mg/L,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,174,,,,,11.75,5.1,28.2,pg/mL,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,DMRR,"Guo, Weina (DMRR)",matched (3)
15aug2020 08:42:41,FS6NVVT9,SS,Predictors for Severe COVID-19 Infection.,Peer reviewed,United States,Single center,Cohort study,Upon hospitalization,Retrospective,  3/8/2020,  4/8/2020,Invasive mechanical ventilation,197,197,197,60.6,16.2,,,,47.7,nasopharyngeal swab,,,,,,,,,,.,.,.,,,,,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,74,29,,,,,,,,.,for all parameters,123,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,CID,"Bhargava, Ashish (CID)",matched (3)
12aug2020 00:23:46,G2H4UH3K,SaK,"Venous and arterial thromboembolic complications in COVID-19 patients admitted to an  academic hospital in Milan, Italy.",Peer reviewed,Italy,Single center,Cohort study,Upon hospitalization,Retrospective, 2/13/2020, 4/10/2020,ICU admission,388,388,388,,,66,55,85,32,NA,92,,,,,,,,,.,.,.,296,,,,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,61,12,,,61,55,69,.,.,,,327,112,,,68,55,77,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,Throm. Res.,"Lodigiani, Corrado (Throm. Res.)",matched (3)
16aug2020 15:52:53,H6LL7HW4,SS,"Clinical characteristics, outcomes, and risk factors for mortality in patients with  cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study.",Peer reviewed,China,Multi center,Cohort study,cancer patients,Retrospective, 1/13/2020, 3/18/2020,Mortality,8161,205,205,,,63,56,70,53,nasopharyngeal swabs,40,11,,,63,53,75,19.5,,.,.,for most factors,165,98,,,62,57,69,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,.22,.07,2.5,ng/mL,,,,,,.06,.05,.13,ng/mL,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,12.8,10.7,15.4,pg/mL,,,,,,8.800000000000001,5.7,14.3,pg/mL,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,.,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,Lancet,"Yang, Kunyu (Lancet)",matched (3)
31jul2020 18:43:02,H6TRPFU5,SS,"Clinical features and outcomes of 221 patients with COVID-19 in Wuhan, China",Pre-print,China,Single center,Cohort study,Upon hospitalization,Retrospective,  1/2/2020, 2/10/2020,"ICU admission, ICU mortality (9/55 at end of study)",221,221,221,,,55,39,66.5,51.1,pharyngeal swab,,,,,,,,,,.,.,.,,,,,,,,.,,,,221,113,,,55,39,66.5,,,,.,,,,,,,,,,,,55,20,,,62,52,74,.,.,,,166,93,,,51,36,64.3,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,.,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,Preprint,"Zhang, Guqin  (Preprint)",matched (3)
13aug2020 14:18:44,H8XL3SAP,MG,Longitudinal hematologic and immunologic variations associated with the progression  of COVID-19 patients in China.,Peer reviewed,China,Multi center,Cohort study,Upon hospitalization,Retrospective,  1/1/2020, 3/22/2020,Mortality,548,548,548,56,14.5,,,,235,NA,103,34,66.90000000000001,12.1,,,,,,.,.,.,445,101,53.5,13.9,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,89,,,,,108.9,55.7,160,mg/L,410,,,,,27.6,6.33,72.84999999999999,mg/L,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,84,,,,,.14,.08,.33,ng/mL,393,,,,,.05,.05,.07,ng/mL,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,81,,,,,9.74,7.53,13.22,pg/mL,337,,,,,7.24,5.58,9.779999999999999,pg/mL,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,182,136.5,230,/µL,NA,,,,,361,232.5,567.5,.,,.,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,JACI,"Chen, Ruchong (JACI)",matched (3)
09aug2020 12:19:01,HVBHAKAJ,MG,Characteristics of Hospitalized Adults With COVID-19 in an Integrated Health Care  System in California.,Peer reviewed,United States,Multi center,Cohort study,Upon hospitalization,Retrospective,  3/1/2020, 3/31/2020,ICU admission,16201,1299,377,,,61,50,73,43.8,nasal/throat swaps,50,,,,,,,,,.,.,.,271,,,,,,,.,,,,377,165,,,61,50,73,,,,.,922,,,,,,,,,,,113,39,,,63,53,73,.,.,,,264,126,,,60,49,72,,,,,110,,,,,,,,,.,.,267,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,JAMA,"Myers, Laura C. (JAMA)",matched (3)
16aug2020 15:44:28,I269HPVV,SS,"Early decrease in blood platelet count is associated with poor prognosis in COVID-19  patients-indications for predictive, preventive, and personalized medical approach.",Peer reviewed,China,Single center,Cohort study,Upon hospitalization,Retrospective,  1/7/2020, 2/28/2020,Mortality,1066,532,532,,,,,,,upper respiratory tract specimens,29,15,64.7,13.1,,,,5.77,,.,.,.,503,271,48.2,14.4,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,EPMA,"Zhao, Xiaofang (EPMA)",matched (3)
11aug2020 11:51:24,I9VLJ996,SaK,"Clinical determinants for fatality of 44,672 patients with COVID-19.",Peer reviewed,China,Multi center,re-analysis of the largest confirmed case series reported publicly by the Chinese center for disease control and prevention,In the community,Retrospective,1/1/0101, 2/11/2020,Mortality,44672,44672,44672,,,,,,48.6,NA,1023,370,,,,,,2.3,,.,.,.,43649,21321,,,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,Crit Care,"Deng, Guangtong (Crit Care)",matched (3)
15jul2020 16:34:19,IAGJ377U,SK,Characteristics of COVID-19 infection in Beijing.,Peer reviewed,China,Multi center,Cohort study,Upon hospitalization,Retrospective, 1/20/2020, 2/10/2020,Hospitalization,262,262,262,,,47.5,,,,throat swab,3,,,,,,,,,.,.,.,45,,,,,,,.,,,,262,,,,47.5,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,J. Inf.,"Tian, Sijia (J. Inf.)",matched (3)
23jul2020 19:38:56,IF2C6VLK,SK,"Clinical course and risk factors for mortality of adult inpatients with COVID-19  in Wuhan, China: a retrospective cohort study.",Peer reviewed,China,Multi center,Cohort study,Upon hospitalization,Retrospective,12/29/2019, 1/31/2020,Mortality,813,191,191,,,56,46,67,38,throat swab,54,16,,,69,63,76,,,.,.,.,137,56,,,52,45,58,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,54,,,,,.1,.1,.5,ng/mL,137,,,,,.1,.1,.1,ng/mL,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,54,,,,,11,7.5,14.4,pg/mL,137,,,,,6.3,5,7.9,pg/mL,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,Lancet,"Zhou, Fei (Lancet)",matched (3)
16aug2020 15:49:56,IHIFK5SK,SS,Acute Physiology and Chronic Health Evaluation II Score as a Predictor of Hospital  Mortality in Patients of Coronavirus Disease 2019.,Peer reviewed,China,Single center,Cohort study,ICU admission,Retrospective, 1/10/2020, 2/10/2020,Mortality,178,154,154,60.68,13,,,,56.49,#,52,32,68.98,9.220000000000001,,,,33.77,,.,yes for scores,.,102,55,56.45,12.64,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,CCM,"Zou, Xiaojing (CCM)",matched (3)
16aug2020 15:53:51,IPHVT9RV,SS,Factors Associated With Intubation and Prolonged Intubation in Hospitalized Patients  With COVID-19.,Peer reviewed,United States,Multi center,Cohort study,Upon hospitalization,Retrospective,  3/1/2020,  4/8/2020,Invasive mechanical ventilation,564,486,486,,,59,47,69,44.2,nasopharyngeal swab,,,,,,,,,,.,.,.,,,,,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,138,50,,,,,,,,yes,yes,348,165,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,.,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,AAOHNS,"Hur, Kevin (AAOHNS)",matched (3)
05aug2020 16:49:23,IWC8V9PB,SS,"Association of clinical and radiographic findings with the outcomes of 93 patients  with COVID-19 in Wuhan, China.",Peer reviewed,China,Single center,Cohort study,Upon hospitalization,Retrospective, 1/10/2020, 2/22/2020,Mortality,93,93,93,51,17.5,,,,56,#,25,10,69,10.5,,,,27,,.,.,.,68,42,43.7,13.1,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,25,77,44,,,,,,mg/L,68,,,,,7.7,3.9,15.7,mg/L,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,.,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,Theranostics,"Li, Lingli (Theranostics)",matched (3)
06jul2020 20:14:07,J8KXG38Q,CG,Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.,Peer reviewed,China,Single center,Cohort study,Upon hospitalization,Retrospective,  1/1/2020,  2/3/2020,Mortality,183,183,183,54.1,16.2,,,,85,not specified,21,5,64,20.7,,,,,,.,.,.,162,80,52.4,15.6,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,JTH,"Tang, Ning (JTH, 03/20)",matched (3)
12jul2020 12:49:15,JEMB36NJ,SK,"Influence factors of death risk among COVID-19 patients in Wuhan, China: a hospital-based case-cohort study",Pre-print,China,Single center,Cohort study,Upon hospitalization,Retrospective,  1/1/2020, 1/30/2020,Mortality,220,200,200,,,,,,50.5,throat swab,34,18,,,,,,,,.,.,.,166,83,,,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,Preprint,"Fu, Lin  (Preprint)",matched (3)
06aug2020 16:33:26,JKSRRY6U,SS,Characterization and clinical course of 1000 Patients with COVID-19 in New York:  retrospective case series.,Peer reviewed,United States,Single center,Cohort study,emergency department or hospitalization,Retrospective, 3/11/2020,  4/6/2020,"Hospitalization, ICU admission",2423,1000,1000,,,63,50,75,40.4,#,,,,,,,,,,.,.,.,,,,,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,236,78,,,62,52,72,.,.,,,614,261,,,64,51,77,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,.,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,Preprint,"Argenziano, Michael G. (Preprint)",matched (3)
16aug2020 15:57:36,JV3YMN3A,SS,Cardiac injuries in patients with coronavirus disease 2019: Not to be ignored.,Peer reviewed,China,Single center,Cohort study,ICU admission,Retrospective,12/30/2019,2/16/0202,Mortality,73,73,73,58.36,14.31,,,,32.88,#,47,15,65.45999999999999,9.74,,,,64.38,,.,.,.,26,9,46.23,12.01,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,47,,,0,5,118.2,75,160,mg/L,26,,,0,5,52.1,17,80.59999999999999,mg/L,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,47,,,0,7,9.1,7,13.1,pg/mL,26,,,0,7,4.9,4,6.3,pg/mL,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,IJID,"Fan, Hua (IJID)",matched (3)
16aug2020 15:33:44,KILN4T6F,SS,COVID-19 in elderly kidney transplant recipients.,Peer reviewed,Spain,Single center,Cohort study,kidney transplant patients 65 years and older,Prospective, 3/12/2020,  4/4/2020,Mortality,324,16,16,73.59999999999999,4.7,,,,25,nasopharyngeal swab or bronchoalveolar lavage,8,3,74.59999999999999,5.3,,,,50,,.,.,.,8,1,72.59999999999999,4.2,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,8,187.5,88.90000000000001,,,,,,mg/L,8,111.8,67.7,,,,,,mg/L,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,8,2.3,2.1,,,,,,ng/mL,8,1.03,1,,,,,,ng/mL,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,.,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,AJT,"Crespo, Marta (AJT)",matched (3)
25jun2020 20:27:36,KQ2KIUJ9,SK,Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan: A Retrospective Observational Study.,Peer reviewed,China,Multi center,Cohort study,Upon hospitalization,Retrospective,  1/9/2020, 2/15/2020,Mortality,85,85,85,65.8,14.2,,,,27.1,throat swab,85,23,65.8,14.2,,,,2.7,,.,.,.,,,,,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,85,107.259,117.215,,,,,,mg/L,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,85,3.65,13.398,,,,,,ng/mL,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,RCCM,"Du, Yingzhen (RCCM)",matched (3)
09aug2020 22:23:24,KYVP9NGS,AM,Clinical characteristics and short-term outcomes of patients with coronavirus  disease 2019: a retrospective single-center experience of a designated hospital in  Poland.,Peer reviewed,Poland,Single center,Cohort study,Upon hospitalization,Retrospective, 3/16/2020,  4/7/2020,Mortality,169,169,169,63.7,19.6,,,,48.5,nasal or pharyngeal swab specimens,46,16,75.3,11.9,,,,,,.,.,.,123,66,59.3,20.1,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,PAMW,"Nowak, Błażej (PAMW)",matched (3)
12aug2020 14:55:36,LQ2U5TW5,MG,"CLINICAL CHARACTERISTICS OF 28 PATIENTS WITH DIABETES AND COVID-19 IN WUHAN, CHINA.",Peer reviewed,China,Single center,Cohort study,Upon hospitalization,Retrospective, 1/29/2020, 2/10/2020,"ICU admission, Invasive mechanical ventilation, Mortality",28,28,28,68.59999999999999,9,,,,7,#,12,,,,,,,,,.,.,.,16,,,,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,14,4,71.40000000000001,7.9,,,,.,.,,,14,3,65.8,9.4,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,,,14,,,0,,134.6,73.2,164.1,mg/L,14,,,0,1,12.9,3.5,55.7,mg/L,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,14,,,.02,.05,.31,.1,3.08,ng/mL,14,,,.02,.05,.03,.03,.06,ng/mL,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,14,,,0,7,124.5,65.09999999999999,199.9,pg/mL,14,,,0,7,13,2.4,39.8,pg/mL,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,.,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,EP,"Wang, Feng (EP)",matched (3)
16aug2020 15:31:02,LTZQ8ZKC,SS,"Clinical characteristics of 34 COVID-19 patients admitted to intensive care unit in  Hangzhou, China.",Peer reviewed,China,Single center,Cohort study,ICU admission,Retrospective, 1/22/2020,  3/3/2020,Invasive mechanical ventilation,34,34,34,,,66,58,76,32.4,"sputum, pharyngeal swabs, bronchoalveolar lavage fluid, and bronchial aspirates",,,,,,,,,,.,.,.,,,,,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,15,4,,,71,60,83,,,.,.,19,7,,,66,51,72,,,,,,,,,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,15,,,0,8,50,39,52,mg/L,19,,,0,8,46,27,103,mg/L,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,15,,,0,7,65,38,202,pg/mL,19,,,0,7,38,12,72,pg/mL,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,.,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,JZUS,"Zheng, Yi (JZUS)",matched (3)
14aug2020 21:58:21,MH98ATHR,SaK,Survival study of hospitalised patients with concurrent COVID-19 and haematological  malignancies.,Peer reviewed,Spain,Single center,Cohort study,Upon hospitalization,Retrospective,  3/9/2020, 4/17/2020,Mortality,34,34,34,,,72.5,,,15,nasopharyngeal swab,11,6,,,83,,,,,.,.,.,23,9,,,71,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,2,,,,,,,.,.,,,32,,,,,,,,,,,4,,,,,,,,,.,.,30,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,11,,,,,117,,,mg/L,23,,,,,111,,,mg/L,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,11,,,,,1,,,ng/mL,23,,,,,.2,,,ng/mL,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,BJH,"Martín-Moro, Fernando (BJH)",matched (3)
09aug2020 11:02:05,MPKQCF8H,SS,Factors associated with death outcome in patients with severe coronavirus disease-19  (COVID-19): a case-control study.,Peer reviewed,China,Single center,Cohort study,Upon hospitalization,Retrospective, 1/27/2020, 3/19/2020,Mortality,211,124,124,,,68,61,75,31.5,#,89,22,,,69,61,73,,,,.,.,35,17,,,65,49,77,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,89,,,0,8,85.86,51.35,116.83,mg/L,35,,,0,8,53.57,30.28,78.56,mg/L,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,89,,,0,.05,.25,.12,.44,ng/mL,35,,,0,.05,.09,.06,.17,ng/mL,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,Int. Journ. Med. Sci.,"Pan, Feng (Int. Journ. Med. Sci.)",matched (3)
23jun2020 19:29:26,MTP9TMS5,SK,"Epidemiological and Clinical Characteristics of 17 Hospitalized Patients with 2019 Novel Coronavirus Infections Outside Wuhan, China",Pre-print,China,Single center,Cohort study,Upon hospitalization,Retrospective, 1/22/2020, 2/10/2020,Hospitalization,17,17,17,45.1,12.8,,,,47.1,throat swab,,,,,,,,,,.,.,.,,,,,,,,.,,,,12,7,49.4,11.7,,,,,,,.,5,1,34.8,9.199999999999999,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,12,33.4,38.7,,,,,,mg/L,5,28.6,21.4,,,,,,mg/L,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,12,69,67,,,,,,ng/mL,5,.05,34,,,,,,ng/mL,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,Preprint,"Jie, Li (Preprint)",matched (3)
16aug2020 15:40:32,MWL3Z8AF,SS,Neutrophil to lymphocyte ratio as prognostic and predictive factor in patients with  coronavirus disease 2019: A retrospective cross-sectional study.,Peer reviewed,China,Single center,Cohort study,Upon hospitalization,Retrospective, 1/11/2020,  3/3/2020,"Mortality, NLR",1004,1004,1004,,,,,,51.7,throat swab,40,13,,,68,58,79,4.15,,.,.,for a few factors,964,498,,,62,50,70,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,40,,,,,.2084600000000001,.11747,.28478,mg/L,964,,,,,.01889,.00368,.06691,mg/L,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,JMV,"Yan, Xisheng (JMV)",matched (3)
10aug2020 17:22:52,NA7J6RBM,MG,Image-proven thromboembolism in patients with severe COVID-19 in a tertiary critical  care unit in the United Kingdom.,Peer reviewed,United Kingdom,Single center,Cohort study,ICU admission,Retrospective,  3/1/2020, 3/31/2020,"Invasive mechanical ventilation, Mortality",79,66,66,,,59,49,66,27,#,22,8,,,64,57,72,,,.,.,.,46,10,,,55,45,64,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,52,,,,,,,,,.,.,14,,,,,,,,,,,,,,,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,20,,,,,1.1,.7,8.199999999999999,ng/mL,46,,,,,1,.3,3.3,ng/mL,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,.,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,Throm. Res.,"Desborough, Michael J. R. (Throm. Res.)",matched (3)
05aug2020 18:19:25,NFIHBWKB,AM,"Risk factors for adverse clinical outcomes with COVID-19 in China: a multicenter,  retrospective, observational study.",Peer reviewed,China,Multi center,Cohort study,Upon hospitalization,Retrospective, 1/10/2020, 3/13/2020,"ICU admission, Invasive mechanical ventilation, Mortality",719,703,703,46.1,15.2,,,,46,#,33,9,64.7,13.4,,,,,,.,.,.,659,310,45,14.6,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,46,,,,,,,.,.,,,657,,,,,,,,,,,20,,,,,,,,,.,.,683,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,Theranostics,"Xu, Peng Peng (Theranostics)",matched (3)
11aug2020 20:47:31,NR77DU69,MG,High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic  liver disease and cirrhosis: Preliminary results from an international registry.,Peer reviewed,United Kingdom,Multi center,Cohort study,reporting registry ,Retrospective, 3/25/2020, 4/20/2020,"ICU admission, Invasive mechanical ventilation, Mortality",152,152,152,,,61,48,71,41.1,NA,47,17,,,64,57,73,,,.,.,.,105,44,,,60,46,70,,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,.,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,Journ. Hep.,"Moon, Andrew M. (Journ. Hep.)",matched (3)
14aug2020 18:21:19,P7S9CPSD-1,SS,Clinical and laboratory predictors of in-hospital mortality in patients with,Peer reviewed,China,Single center,Cohort study,Upon hospitalization,Retrospective,  1/7/2020, 2/11/2020,Mortality,748,302,296,47.32,14.95,,,,52.7,Respiratory tract or blood,19,8,65.59999999999999,12.6,,,,6.42,,.,.,.,277,148,46,14.4,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,19,,,,,88.59999999999999,59.7,118,mg/L,277,,,,,11.4,2.2,27.9,mg/L,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,CID,"Wang, Kun (CID) Training cohort",matched (3)
15aug2020 02:52:12,P7S9CPSD-2,SS,Clinical and laboratory predictors of in-hospital mortality in patients with,Peer reviewed,China,Single center,Cohort study,Upon hospitalization,Retrospective,  1/1/2020, 2/20/2020,Mortality,50,44,44,55.2,16.8,,,,45.5,Respiratory tract or blood,14,4,69,13.4,,,,31.82,,.,.,.,30,16,48.8,14.2,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,14,,,,,98,85.5,117.8,mg/L,30,,,,,39.9,11.9,68.90000000000001,mg/L,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,"Wang, Kun (CID) Validation cohort",matched (3)
09aug2020 13:14:52,PZ3FFPGY,MG,Clinical Characteristics of Hospitalized Covid-19 Patients in New York City.,Pre-print,United States,Multi center,Cohort study,Upon hospitalization,Retrospective, 2/27/2020,  4/2/2020,Mortality,2199,2199,1078,,,65,54,76,41.2,nasopharygnal swaps,310,119,,,75,64,85,,,.,.,.,768,332,,,59,45,72,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,141,,,,,162,75.7,266,mg/L,422,,,,,79.3,37.5,144,mg/L,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,138,,,,,.44,.16,1.45,ng/mL,392,,,,,.09,.05,.22,ng/mL,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,Preprint,"Paranjpe, Ishan (Preprint)",matched (3)
16aug2020 16:01:21,PZQYAFQU,SS,"Clinical Characteristics, Associated Factors, and Predicting COVID-19 Mortality  Risk: A Retrospective Study in Wuhan, China.",Peer reviewed,China,Single center,Cohort study,Upon hospitalization,Retrospective, 1/14/2020, 2/28/2020,"Hospitalization, Mortality",1663,1663,1464,,,64,51,71,49.7,oral pharyngeal swab,212,62,,,69,62.5,77,14.48,,.,.,yes for a number of factors,1252,666,,,62.5,49,70,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,AMEPRE,"Yu, Caizheng (AMEPRE)",matched (3)
22aug2020 11:53:41,Q7Q2HAUD,AM,Association of Digestive Symptoms and Hospitalization in Patients with SARS-CoV-2  Infection.,Peer reviewed,United States,Single center,Cohort study,confirmed COVID-19,Retrospective,  3/3/2020,  4/7/2020,"Hospitalization, ICU admission",207,207,207,,,49,34,65,49.8,#,4,,,,,,,,,.,.,.,203,,,,,,,.,,,,60,28,,,62,43,77,,,,.,147,75,,,43,31,58,,,,,17,7,,,55,42,70,.,.,,,43,21,,,65,45,77,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,Preprint,"Cholankeril, George (Preprint)",matched (3)
16aug2020 15:47:11,QF8STSRR,SS,Clinical characteristics of 46 pregnant women with a severe acute respiratory  syndrome coronavirus 2 infection in Washington State.,Peer reviewed,United States,Multi center,Cohort study,"pregnant women in Washington State, USA",Retrospective, 1/21/2020, 4/17/2020,Hospitalization,46,46,46,,,29,26,34,100,#,,,,,,,,,,.,.,.,,,,,,,,.,,,,7,7,,,,,,,,,.,39,39,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,6,,,,,7.6,1.6,9.9,mg/L,2,,,,,.45,.4,.5,mg/L,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,AJOG,"Lokken, Erica M. (AJOG)",matched (3)
08aug2020 22:56:04,QW5GN992,SaK,"Clinical features of 95 sequential hospitalised patients with novel coronavirus 2019  disease (COVID-19), the first UK cohort.",Peer reviewed,United Kingdom,Single center,Cohort study,Upon hospitalization,Retrospective, 3/10/2020, 3/30/2020,Mortality,95,95,95,,,75,59,82,37,NA,20,8,,,77,72,85,,,.,.,.,75,27,,,74,56,82,.,,,,95,35,,,75,59,82,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,6,,,,,,,,,.,.,85,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,20,,,,6,77,53,124,mg/L,72,,,,6,36,14,67,mg/L,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,J. Inf.,"Tomlins, Jennifer (J. Inf.)",matched (3)
22aug2020 11:54:52,RCR7GILC,MG,Clinical and laboratory findings from patients with COVID-19 pneumonia in Babol  North of Iran: a retrospective cohort study.,Peer reviewed,Iran,Multi center,Cohort study,Upon hospitalization,Retrospective, 2/25/2020, 3/12/2020,"Invasive mechanical ventilation, Mortality",110,100,100,60.12,13.87,,,,49,#,19,8,69.26000000000001,,11.1,,,,,.,.,.,81,40,57.74,13.58,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,43,,,,,,,,,.,.,53,,,,,,,,,,,,,,,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,19,,,,,92,,,mg/L,81,,,,,47.15,,,mg/L,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,.,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,RJIM,"Javanian, Mostafa (RJIM)",matched (3)
10jul2020 20:28:30,RNETXBCW,SK,Elevated serum IgM levels indicate poor outcome in patients with coronavirus disease 2019 pneumonia: A retrospective case-control study,Pre-print,China,Single center,Cohort study,Upon hospitalization,Retrospective, 2/23/2020, 3/11/2020,Mortality,116,116,116,,,61.1,51,69,44,throat swab,15,3,,,68.90000000000001,57,79,,,.,.,.,101,48,,,60,50,69,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,Preprint,"Wang, Zhihua (Preprint)",matched (3)
15aug2020 09:45:17,RWZ9NV42,SS,Coronavirus disease-2019 in cancer patients. A report of the first 25 cancer  patients in a western country (Italy).,Peer reviewed,Italy,Single center,Cohort study,Upon hospitalization,"unclear, probably prospective", 2/21/2020, 3/18/2020,Mortality,25,25,25,71.64,10.08,,,,20,nasal-pharyngeal swap,9,4,74.44,7.21,,,,36,,.,.,.,16,1,68.38,10.16,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,9,148.2,75.40000000000001,,,,,,mg/L,16,93.3,48.7,,,,,,mg/L,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,FON,"Stroppa, Elisa Maria (FON)",matched (3)
15aug2020 15:44:29,SMRLWISA,AM,Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results  from a single Italian Centre study on tocilizumab versus standard of care.,Peer reviewed,Italy,Single center,Cohort study,Upon hospitalization,Retrospective, 2/29/2020,  4/6/2020,Invasive mechanical ventilation,111,111,111,58.5,13.6,,,,30.6,upper respiratory tract,4,,,,,,,,17,case-fatality in TOCI group,.,.,107,,,,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,26,,,,,,,.,.,,,85,,,,,,,,,,,26,,,,,,,,,.,.,85,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,26,,,,,114.6,5.25,210,mg/L,16,,,,,59.3,21.6,112.7,mg/L,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,26,,,,,78.8,46,161,pg/mL,16,,,,,58,28.45,78.5,pg/mL,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,JCV,"Quartuccio, Luca (JCV)",matched (3)
28jun2020 22:39:26,SWEIT7GY,SK,"Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China.",Peer reviewed,China,Single center,Cohort study,Upon hospitalization,Retrospective,  2/9/2020, 2/15/2020,Hospitalization,38,38,38,65.8,16.6,,,,34.2,throat swab / CT Scan / Symptom screen,,,,,,,,,,.,.,.,,,,,,,,.,,,,38,13,65.8,16.6,68,53,76,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,38,51.7,63,,,,,,mg/L,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,JAMA Opth,"Wu, Ping (JAMA Opth)",matched (3)
22aug2020 11:54:19,SZ2FL7HY,AM,"Epidemiological and clinical features of 200 hospitalized patients with corona virus  disease 2019 outside Wuhan, China: A descriptive study.",Peer reviewed,China,Single center,Cohort study,Upon hospitalization,Retrospective, 1/30/2020,  2/8/2020,ICU admission,200,200,200,55,17.1,,,,51,Throat-swab,15,,,,,,,,,.,.,.,185,,,,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,29,13,71,13.4,,,," case fatality in ICU - 51,7 ",.,,,171,89,52,16.2,,,,,,,,16,,,,,,,,,.,.,184,,,,,,,,,,,.,,,.,,29,,,,,68.8,53.47,108.25,mg/L,171,,,,,18.7,6.3,37.9,mg/L,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,JCV,"Yang, Luhuan (JCV)",matched (3)
05jul2020 13:19:34,TIGUKN74,CG,"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.",Peer reviewed,China,Single center,Cohort study,Upon hospitalization,Retrospective,  1/1/2020, 1/28/2020,ICU admission,0,138,138,,,56,42,68,63,throat swab,,,,,,,,,,.,.,.,,,,,,,,.,,,,138,63,,,56,42,68,,,,.,,,,,,,,,,,,36,14,,,66,57,78,.,.,,,102,49,,,51,37,62,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,27,,,,,,,,ng/mL,22,,,,,,,,ng/mL,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,JAMA,"Wang, Dawei (JAMA)",matched (3)
11aug2020 10:17:55,UBRGFEWH,SaK,Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in,Peer reviewed,Germany,Multi center,Cohort study,Upon hospitalization,Retrospective, 2/29/2020,  4/9/2020,Invasive mechanical ventilation,115,89,89,,,61,,,30,NA,,,,,,,,,,.,.,.,,,,,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,32,3,,,65,,,,,.,.,57,24,,,58,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,32,,,,,93,,,mg/L,57,,,,,20,,,mg/L,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,32,,,,,.2,,,ng/mL,57,,,,,0,,,ng/mL,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,32,,,,,95.40000000000001,,,pg/mL,57,,,,,23.2,,,pg/mL,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,JACI,"Herold, Tobias (JACI)",matched (3)
16aug2020 15:42:34,UNHTMU7T,SS,Incidence of venous thromboembolism in hospitalized patients with COVID-19.,Peer reviewed,Netherlands,Single center,Cohort study,Upon hospitalization,Retrospective,  3/2/2020, 4/12/2020,"ICU admission, incidence of venous thromboembolism (VTE)",199,198,198,61,14,,,,34,nose/ throat swab or sputum sample,,,,,,,,,,.,.,.,,,,,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,75,17,62,10,,,,.,.,,,123,51,60,16,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,some for VTE,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,.,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,JTH,"Middeldorp, Saskia (JTH)",matched (3)
14aug2020 21:00:10,V245SXAP,AM,Clinical course and risk factors for mortality of COVID-19 patients with  pre-existing cirrhosis: a multicentre cohort study.,Peer reviewed,China,Multi center,Cohort study,Upon hospitalization,Retrospective,12/31/2019, 3/24/2020,Mortality,21,21,21,,,68,52,75,47.6,#,5,1,,,68,50,75,,,.,.,.,16,9,,,69,52,75,.,,,,,,,,,,,,,,.,,,,,,,,,,,,5,,,,,,,.,.,,,16,,,,,,,,,,,3,,,,,,,,,.,.,18,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,5,,,,,50,13.91,116.4,mg/L,16,,,,,7.2,1.5,56.13,mg/L,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,5,,,,,.1,.05,1.19,ng/mL,16,,,,,.04,0,.09,ng/mL,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,GUT,"Qi, Xiaolong (GUT)",matched (3)
12jul2020 13:35:30,V2CX6I74,SK,"Clinical Features of Patients Infected with the 2019 Novel Coronavirus (COVID-19) in Shanghai, China",Pre-print,China,Single center,Cohort study,Upon hospitalization,Retrospective, 1/20/2020, 2/15/2020,ICU admission,199,198,198,50.1,16.3,,,,49,throat swab,,,,,,,,,,.,.,.,,,,,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,19,2,63.7,16.8,,,,.,.,,,179,95,48.6,15.6,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,19,,,0,.05,.03,.02,.06,ng/mL,175,,,0,.05,.03,.02,.06,ng/mL,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,decreased (<500 cells/mm3),,,410,1590,198,116,340,/µL,normal (500-1400 cells/mm3),,,410,1590,468,309.5,679.5,/µL,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,Preprint,"Cao, Min (Preprint)",matched (3)
10jul2020 21:26:38,V7UJF2FR,SK,Clinical characteristics of 82 death cases with COVID-19,Pre-print,China,Single center,Cohort study,Upon hospitalization,Retrospective, 1/11/2020, 2/10/2020,Mortality,1334,82,82,,,72.5,65,80,34.1,throat swab,82,28,,,72.5,65,80,,,.,.,.,,,,,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,82,,,,,.3,.1,1.1,ng/mL,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,82,,,,,93.8,64.5,258,pg/mL,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,Preprint,"Zhang, Bicheng  (Preprint)",matched (3)
18jul2020 12:58:33,VN52PHAB,CG,Development and external validation of a prognostic multivariable model on admission for hospitalized patients with COVID-19,Pre-print,China,Multi center,Cohort study,Upon hospitalization,Retrospective,  1/1/2020, 2/28/2020,Mortality,299,299,299,,,65,54,73,155,not specified,155,69,,,69,62,76,,,.,.,.,144,69,,,56,47.8,67,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,155,,,,,972,472,1488,mg/L,144,,,,,390,107,806,mg/L,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,Preprint,"Xie, Jianfeng (Preprint) Training cohort",matched (3)
18jul2020 12:58:29,VN52PHAB-VAL,CG,Development and external validation of a prognostic multivariable model on admission for hospitalized patients with COVID-19; VALDIATION COHORT,Pre-print,China,Multi center,Cohort study,Upon hospitalization,Retrospective,  1/1/2020, 2/28/2020,Mortality,151,151,151,,,56,47,68,50,not specified,69,25,67,,67,61,73,,,.,.,.,76,25,,,47,40.8,53.3,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,69,,,,,1121,654,1600,mg/L,76,,,,,264,75,618,mg/L,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,"Xie, Jianfeng (Preprint) Validation cohort",matched (3)
12aug2020 16:14:15,VPU3IXE7,SaK,"Venous thromboembolism in SARS-CoV-2 patients: only a problem in ventilated ICU  patients, or is there more to it?",Peer reviewed,Belgium,Single center,Cohort study,Upon hospitalization,Retrospective,  4/3/2020,  4/3/2020,ICU admission,82,82,82,,,,,,,NA,9,,,,,,,,,.,.,.,73,,,,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,30,10,64.5,11.8,,,,.,.,,,52,24,63.6,14.4,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,Europ. Resp. Journ.,"Criel, Maarten (Europ. Resp. Journ.)",matched (3)
28jun2020 16:47:58,VUCZN22G,SK,Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease.,Peer reviewed,China,Multi center,Cohort study,Upon hospitalization,Retrospective,12/30/2019, 1/15/2020,Hospitalization,78,78,78,,,38,33,57,50,throat swab,,,,,,,,,,.,.,.,,,,,,,,.,,,,78,39,,,38,33,57,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,78,,,,,11.1,2.3,36,mg/L,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,78,,,,,.06,.04,.1,ng/mL,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,CM,"Liu, Wei (CM)",matched (3)
16aug2020 15:33:17,VWYPDQ3L,AM,Obesity as a risk factor for poor outcome in COVID-19-induced lung injury: the  potential role of undiagnosed obstructive sleep apnoea.,Peer reviewed,United States,Single center,Cohort study,Upon hospitalization,Retrospective,  1/1/2000,12/31/2000,ICU admission,124,124,124,,,,,,30.65,#,,,,,,,,,,.,.,.,,,,,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,60,16,,,,,,.,.,,,64,22,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,BJA,"Memtsoudis, Stavros G. (BJA)",matched (3)
16aug2020 15:54:45,W947CMCM,SS,"Suppressed T cell-mediated immunity in patients with COVID-19: A clinical  retrospective study in Wuhan, China.",Peer reviewed,China,Single center,Cohort study,Upon hospitalization,Retrospective,12/26/2019,  3/1/2020,Mortality,187,187,187,,,62,48.5,71,44.9,Maternal throat swab,28,11,,,73,68,77.25,14.97,,.,.,for T lymphocyte subsets,117,58,,,56,43,66,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,28,,,,,91,52.56,122.38,mg/L,117,,,,,16.91,4.04,51.37,mg/L,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,28,,,,,29.8,14.6,63.89,pg/mL,117,,,,,14.65,4.24,27,pg/mL,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,84.5,59.75,148,/µL,NA,,,,,256,159,334,/µL,,.,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,J. Inf.,"Xu, Bo (J. Inf.)",matched (3)
15jul2020 17:15:50,W9QKA6BG,SK,"Liver impairment in COVID-19 patients: a retrospective analysis of 115 cases from a single center in Wuhan city, China.",Peer reviewed,China,Single center,Cohort study,Upon hospitalization,Retrospective, 1/18/2020, 2/22/2020,Hospitalization,240,121,115,49.52,17.06,,,,57.4,throat swab,1,,,,,,,,,.,.,.,,,,,,,,,,,,115,66,49.52,17.06,,,,,,,.,,,,,,,,,,,,7,3,68.14,10.96,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,115,35.12,51.81,0,10,,,,mg/L,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,LIV,"Zhang, Yafei (LIV)",matched (3)
24jun2020 20:56:48,WMKSY46T,SK,"Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID-19) in Wuhan, China: a retrospective study.",Peer reviewed,China,Multi center,Cohort study,Upon hospitalization,Retrospective,  1/1/2020, 2/21/2020,Mortality,964,225,225,,,,,,,throat swab,109,36,,,69,62,74,,,.,.,.,116,65,,,40,33,57,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,109,,,,,109.25,35,170.28,mg/L,116,,,,,3.22,1.04,21.8,mg/L,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,CM,"Deng, Yan (CM)",matched (3)
15aug2020 14:45:41,WPLSA9R3,SS,Clinical Outcomes of COVID-19 with Evidence-Based Supportive Care.,Peer reviewed,United States,Single center,Cohort study,In the community,Retrospective,  3/6/2020, 4/22/2020,"Hospitalization, ICU admission",1099,135,135,,,46.5,33,56,34.8,#,,,,,,,,,,.,.,.,,,,,,,,.,,,,15,3,,,50.5,41.2,58,,,,.,114,42,,,43,30.5,55,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,CID,"Larson, Derek T. (CID)",matched (3)
14aug2020 01:09:46,WRWJWA3Q,SaK,"Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge  Conditions, Northern California, USA, March-April 2020.",Peer reviewed,United States,Multi center,Cohort study,Upon hospitalization,Retrospective, 3/13/2020, 4/11/2020,ICU admission,72,72,72,,,60.4,43.4,70.59999999999999,34,"nasopharyngeal, oropharyngeal, endotracheal aspirate, and bronchoalveolar lavage samples",6,,,,,,,,,.,.,.,68,,,,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,21,8,,,57.6,42.2,70.09999999999999,.,.,,,51,26,,,61.7,46.6,72.90000000000001,,,,,13,,,,,,,,,.,.,59,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,EID,"Ferguson, Jessica (EID)",matched (3)
14aug2020 11:44:32,WSE7WTFK,MG,A report from the Brescia Renal COVID Task Force on the clinical characteristics  and short-term outcome of hemodialysis patients with SARS-CoV-2 infection.,Peer reviewed,Italy,Multi center,Cohort study,Symptom based / random tests in dialyisis center,Prospective,  3/1/2020,  4/3/2020,"Hospitalization, Mortality",643,94,94,,,72,62,79,32,NA,24,,,,,,,,,.,.,.,70,,,,,,,,,,,57,18,,,73,64,80,,,,.,37,13,,,67,60,77,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,,,.,,,,,,,,,.,57,,,,,60,19,89,mg/L,37,,,,,12.8,3.7,33.8,mg/L,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,.,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,KINT,"Alberici, Federico (KINT)",matched (3)
12jul2020 20:42:32,WWADKB4N,SK,Clinical characteristics of 51 patients discharged from hospital with COVID-19 in Chongqing，China,Pre-print,China,Single center,Cohort study,Upon hospitalization,Retrospective, 1/20/2020, 2/11/2020,Hospitalization,51,50,50,45,34,51,,,37.3,throat swab,0,,,,,,,,,.,.,.,50,,,,,,,.,,,,50,19,,,45,34,51,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,50,,,0,5,10.2,2.7,43.8,mg/L,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,50,,,0,46,43,32,68,ng/mL,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,50,,,0,5.4,0,0,8.4,pg/mL,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,Preprint,"Lei, Liu (Preprint)",matched (3)
16aug2020 15:29:02,XJABSBWI,SS,"Clinical course and outcome of 107 patients infected with the novel coronavirus,",Peer reviewed,China,Multi center,Cohort study,Upon hospitalization,Retrospective, 12/1/2019, 2/10/2020,Mortality,544,544,107,,,51,36,65,46.7,#,19,3,,,73,64,81,17.76,,.,.,yes,88,,,,44.5,35,58.8,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,.,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,Crit. Care,"Wang, Dawei (Crit. Care)",matched (3)
09aug2020 22:14:10,YPI59VLZ,MG,[COVID-19-Response - Strategies of the Task-Force Coronavirus and experiences upon  implementation in the management of 115 cases at the University Medical Center  Freiburg].,Peer reviewed,Germany,Single center,Cohort study,Upon hospitalization,Retrospective, 2/25/2020, 3/31/2020,"ICU admission, Invasive mechanical ventilation, Mortality",115,115,115,,,64,,,,Respiratory Area,17,,,,83,,,,,.,.,.,98,,,,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,37,8,,,68,,,.,.,,,78,,,,60,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,.,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,DMW,"Rieg, Siegbert (DMW)",matched (3)
28jun2020 21:50:38,YUHMYM8R,SK,Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia.,Peer reviewed,China,Single center,Cohort study,Upon hospitalization,Retrospective,  1/7/2020, 2/14/2020,Hospitalization,60,60,60,,,60,38,66,63,throat swab,,,,,,,,,,.,.,.,,,,,,,,.,,,,60,38,,,60,38,66,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,60,,,0,10,26,9,67,mg/L,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,60,,,0,7,13,6,29,pg/mL,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,Inf. Dis,"Wang, Fan (Inf. Dis)",matched (3)
16jul2020 08:33:04,Z2ZKG2E8,SK,Covid-19 in Critically Ill Patients in the Seattle Region - Case Series.,Peer reviewed,United States,Multi center,Cohort study,ICU admission,Retrospective, 2/24/2020,  3/9/2020,ICU admission,24,24,24,64,18,,,,38,throat swab,12,,,,,,,,,.,.,.,,,,,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,24,9,64,18,,,,.,.,,,,,,,,,,,,,,18,,,,,,,,,.,.,,,,,,,,,,,,.,,,.,,10,186.57,104.75,,,,,,mg/L,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,12,.28,.23,,,,,,ng/mL,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NEJM,"Bhatraju, Pavan K. (NEJM)",matched (3)
16aug2020 15:25:50,Z79BVME6,SS,Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a  prospective cohort study.,Peer reviewed,China,Single center,Cohort study,Upon hospitalization,Prospective,12/25/2019,  2/7/2020,Mortality,179,179,179,57.6,13.7,,,,45.8,#,21,11,70.2,7.7,,,,11.7,,.,.,yes,158,71,56,13.5,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,.,,,,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,21,,,,,86.40000000000001,37.9,105.5,mg/L,158,,,,,36,19.3,91,mg/L,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,21,,,,,.1,.1,.5,ng/mL,158,,,,,.1,0,.2,ng/mL,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,68,55.1,148.8,/µL,NA,,,,,128.3,73.5,201.7,/µL,,.,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,Europ. Resp. Journ.,"Du, Rong-Hui (Europ. Resp. Journ.)",matched (3)
16aug2020 15:59:40,ZA527FF6,SS,Compassionate Use of Remdesivir for Patients with Severe Covid-19.,Peer reviewed,United States,Multi center,Cohort study,Upon hospitalization,Prospective, 1/25/2020,  3/7/2020,Invasive mechanical ventilation,61,61,53,,,64,48,71,25,#,,,,,,,,,,.,.,.,,,,,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,34,7,,,67,56,72,,,.,.,19,6,,,53,41,68,,,,,.,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,NA,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NEJM,"Grein, Jonathan (NEJM)",matched (3)
12aug2020 12:38:36,ZGBQ7D4F,MG,Clinical and biochemical characteristics of patients admitted to ICU with,Peer reviewed,Ireland,Single center,Cohort study,ICU admission,Retrospective, 3/23/2020, 4/26/2020,"Invasive mechanical ventilation, Mortality",39,39,39,,,60,53,66,10,NA,5,,,,,,,,,.,.,.,,,,,,,,.,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,.,.,,,,,,,,,,,,,,29,,,,,,,,,.,.,10,,,,,,,,,,,.,,,,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,29,,,,,164.5,122.5,244,mg/L,10,,,,,70.5,38,195,mg/L,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,29,,,,,300,96.25,757.75,pg/mL,10,,,,,36,25,75,pg/mL,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,NA,,,,,,,,.,,.,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,.,,,,,,,,,,.,Med. Int.,"Blake, Alan (Med. Int.)",matched (3)
